As part of a collaboration with the National Malaria Control Program, the government, through the Presidential Malaria Initiative (PMI) and the United States Agency for International Development (USAID), has since from October 28 until November 22, a long-lasting insecticide spraying campaign.
Malaria remains one of the most widespread diseases in Madagascar’s health centers. This year alone, more than two million people have contracted malaria in the country, making it one of the leading causes of medical consultation.
Nearly 109,292 households in four high-risk districts, namely Ivohibe, Isandra, Ankazoabo and Ikalamavony will be treated under this campaign. This effort will protect 569,949 people, including vulnerable groups such as pregnant women and children under five, by applying an insecticide approved by the World Health Organization (WHO) to walls and ceilings .
In partnership with the PMI Evolve project, the National Malaria Control Program (PNLP) will lead this initiative to strengthen the malaria prevention strategy in Ikalamavony. The campaign includes ongoing monitoring to ensure the insecticide remains effective over time, in compliance with environmental regulations.
In Ankazoabo, the 2023 indoor spraying campaign was successfully implemented and covered 94% of homes, protecting over 85,000 people and resulting in a considerable reduction of over 50% in malaria cases in the region . “ These results are due to the hard work and determination of all our community partners “, declared Solofo Razakamiadana, the representative of PMI Madagascar.
The continued support of the American people plays a critical role in achieving the U.S. government’s goals of supporting Madagascar’s National Malaria Control Program, building capacity, and promoting local ownership of future malaria control efforts. malaria.
Health
